Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review

Over the past 20 years, there has been a paradigm shift in the care of patients with non-small cell lung cancer (NSCLC), who now have a range of systemic treatment options including targeted therapy, chemotherapy, immunotherapy (ICI), and antibody–drug conjugates (ADCs). A proportion of these cancer...

Full description

Bibliographic Details
Main Authors: David John McMahon, Ronan McLaughlin, Jarushka Naidoo
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
immunotherapy
oncogene-addicted
oncogene-addicted non-small cell lung cancer
EGFR
ALK
KRAS
Online Access:https://www.mdpi.com/2072-6694/16/3/527

Similar Items

Similar Items